FcÎ³RIIb blockage: a promising immunotherapy target for severe COVID-19.

He, Xuemei; Wang, Manni; Wu, Min

He, Xuemei; Wang, Manni; Wu, Min.

He X; Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, P. R. China.
Wang M; Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, P. R. China.
Wu M; Department of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND, USA. min.wu@und.edu.

Signal Transduct Target Ther ; 6(1): 147, 2021 04 09.

Article in English | MEDLINE | ID: covidwho-1177091

Subject(s)

COVID-19; Humans; Immunologic Factors; Immunotherapy; Receptors, IgG; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: Signal Transduct Target Ther Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google